Atom Investors LP purchased a new position in shares of Cardlytics, Inc. (NASDAQ:CDLX – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 10,196 shares of the company’s stock, valued at approximately $33,000.
A number of other large investors have also made changes to their positions in the business. BNP Paribas Financial Markets grew its stake in Cardlytics by 32.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 19,745 shares of the company’s stock worth $63,000 after buying an additional 4,796 shares during the last quarter. Dynamic Technology Lab Private Ltd purchased a new stake in shares of Cardlytics during the third quarter worth about $153,000. Charles Schwab Investment Management Inc. increased its holdings in shares of Cardlytics by 3.0% during the third quarter. Charles Schwab Investment Management Inc. now owns 390,343 shares of the company’s stock valued at $1,249,000 after acquiring an additional 11,388 shares in the last quarter. Intech Investment Management LLC purchased a new position in shares of Cardlytics in the 3rd quarter valued at approximately $47,000. Finally, Check Capital Management Inc. CA boosted its stake in Cardlytics by 10.4% in the 3rd quarter. Check Capital Management Inc. CA now owns 50,650 shares of the company’s stock worth $162,000 after purchasing an additional 4,775 shares in the last quarter. 68.10% of the stock is owned by institutional investors and hedge funds.
Insider Activity at Cardlytics
In other news, CFO Alexis Desieno sold 25,118 shares of Cardlytics stock in a transaction dated Friday, November 15th. The shares were sold at an average price of $3.43, for a total value of $86,154.74. Following the sale, the chief financial officer now owns 116,481 shares in the company, valued at $399,529.83. This trade represents a 17.74 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Amit Gupta sold 22,607 shares of the business’s stock in a transaction dated Thursday, October 24th. The stock was sold at an average price of $3.85, for a total transaction of $87,036.95. Following the sale, the chief executive officer now directly owns 178,519 shares of the company’s stock, valued at $687,298.15. This represents a 11.24 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 68,691 shares of company stock worth $237,767 in the last 90 days. Corporate insiders own 4.40% of the company’s stock.
Wall Street Analysts Forecast Growth
Get Our Latest Analysis on Cardlytics
Cardlytics Trading Up 0.3 %
Shares of NASDAQ:CDLX opened at $3.83 on Friday. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 2.40. Cardlytics, Inc. has a 12-month low of $2.89 and a 12-month high of $20.52. The business has a 50 day moving average of $3.82 and a two-hundred day moving average of $5.65. The company has a market capitalization of $194.64 million, a PE ratio of -0.63 and a beta of 1.53.
Cardlytics (NASDAQ:CDLX – Get Free Report) last announced its quarterly earnings results on Wednesday, November 6th. The company reported ($0.15) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.33) by $0.18. Cardlytics had a negative net margin of 93.55% and a negative return on equity of 110.67%. The firm had revenue of $67.06 million for the quarter, compared to the consensus estimate of $57.77 million. During the same period in the prior year, the firm posted ($0.26) earnings per share. The firm’s quarterly revenue was down 15.1% compared to the same quarter last year. As a group, analysts forecast that Cardlytics, Inc. will post -1.52 EPS for the current year.
About Cardlytics
Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.
Featured Articles
- Five stocks we like better than Cardlytics
- What is the Dogs of the Dow Strategy? Overview and Examples
- NVIDIA’s Blackwell Chips Set for Arizona Manufacturing by TSMC?
- Compound Interest and Why It Matters When Investing
- Okta: Bullish Signals Suggest a Market Reversal Is Underway
- Why Invest in 5G? How to Invest in 5G Stocks
- BlackRock Makes Waves With $12B Private Credit Acquisition
Want to see what other hedge funds are holding CDLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardlytics, Inc. (NASDAQ:CDLX – Free Report).
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.